Correction To: DTaP‑IPV‑HepB‑Hib Vaccine (Hexyon®): An Updated Review of Its Use in Primary and Booster Vaccination

Paediatric Drugs - United Kingdom
doi 10.1007/s40272-019-00356-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Budget Impact Analisis of Switching From DPT and Monovalent Vaccines to DTaP–IPV-Hib Combined Vaccine Into Russian Immunization Schedule

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Immunogenicity and Safety of a Combined DTPa-IPV/Hib Vaccine Administered as a Three-Dose Primary Vaccination Course in Healthy Korean Infants: Phase III, Randomized Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Response to Diphtheria Booster Vaccination in Healthy Adults: Vaccine Trial

BMJ
2000English

Immune Persistence 17 to 20 Years After Primary Vaccination With Recombination Hepatitis B Vaccine (CHO) and the Effect of Booster Dose Vaccination

BMC Infectious Diseases
Infectious Diseases
2019English

The Effects of Booster Vaccination on Hepatitis B Vaccine in Anti-HBs Negative Infants of HBsAg-positive Mothers After Primary Vaccination

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Global Hib Vaccination: Reasons to Cheer and Fear

The Lancet Global Health
Medicine
2016English

Hib IgG Persistence Following Early Booster Dose

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2005English

Hemophilus Influenzaetypeb(Hib) Vaccine: An Effective Control Strategy in India

Human Vaccines
2011English

Immunogenicity and Safety of a Fully Liquid DTaP-IPV-Hep B-PRP-T Vaccine at 2-4-6 Months of Age in Peru

Journal of Vaccines & Vaccination
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy